Methyltransferase-like 3 (METTL3) regulates tumor metabolic reprogramming by controlling the expression of glucose transporters (GLUTs), lactate dehydrogenase (LDHA), and enolase 1 (ENO1) in tumor cells. This evidence concerns the gene LDHA and neoplasm.